Active ingredients in skincare products typically include peptides, growth factors, antioxidants, anti-inflammatory botanicals, and polysaccharides. Due to their drug-like effects, these products are given the composite name "cosmeceuticals". As natural molecules, peptide substances exhibit unparalleled physiological effects on many skin-related conditions. Initially, interest in peptides in the cosmetics field stemmed from their beneficial effects on wound healing, gradually uncovering their efficacy in combating skin aging.
Although the skin has many layers, it can generally be divided into three main parts:
Each layer also includes connective tissue and collagen fibers to provide support, as well as elastic protein fibers to provide flexibility and strength.
Like all organs, the skin ages as cellular functions and physiological integrity gradually decline. Skin aging is a complex biological process influenced by internal (constitutive) and external (environmental) factors, leading to cumulative changes in skin structure, function, and appearance. Natural pigments seem to offer some protection against sun-induced skin damage. Among endogenous factors, neuroendocrine plays a key role.
With age, the outer layer of skin (epidermis) becomes thinner, even if the number of cell layers remains unchanged. The number of pigment cells (melanocytes) decreases, and the remaining melanocytes increase in volume. Aging skin appears thinner, paler, and more translucent. Pigment spots, including age spots, may appear in sun-exposed areas of the skin. Changes in connective tissue reduce the strength and elasticity of the skin, known as elastosis, which is more apparent in sun-exposed areas. Blood vessels in the dermis become more fragile, leading to bruising, subcutaneous bleeding (commonly called senile purpura), and cherry angiomas (benign red moles). With age, sebum production from sebaceous glands decreases, making it harder for the skin to retain moisture, leading to dryness and itching. The subcutaneous fat layer thins, increasing the risk of skin injury and reducing the ability to maintain body temperature.
Fig 1. Mechanism of neurotransmission. (Gasmi, 2023)
The role of peptides in cosmeceuticals is becoming increasingly prominent, with many anti-aging formulations featuring peptides. Based on the mechanisms of action during skincare, peptides can be roughly categorized into three types:
Name | CAS | Sequence | Effect |
Hexapeptide-3 | 1205679-02-2 | EEMQRR | |
Palmitoyl hexapeptide-12 | 171263-26-6 | Pal-VGVAPG | |
Hexapeptide-9 | 885024-94-2 | Gly-Pro-Gln-Gly-Pro-Gln | Anti-aging |
Myristoyl Hexapeptide-23 | Anti-acne | ||
Palmitoyl Dipeptide-7 | 911813-90-6 | palmitoyl-Lys-Thr-OH | |
Acetyl Hexapeptide-1 | 448944-47-6 | XAHFRW | Protect DNA damage caused by UV exposure |
Palmitoyl tripeptide-1 | 147732-56-7 | palmitoyl-Gly-His-Lys-OH | Repair skin damage |
Myristoyl Pentapeptide-17 | 959610-30-1 | myristoyl-Lys-Leu-Ala-Lys-Lys-NH2 | Skin care and eyelash growth |
Palmitoyl pentapeptide-4/Palmitoyl pentapeptide-3 | 214047-00-4 | palmitoyl-Lys-Thr-Thr-Lys-Ser-OH | Anti-wrinkle |
Myristoyl Hexapeptide-16 | 959610-54-9 | Skin care and eyelash growth | |
Palmitoyl Tripeptide-38 | 1447824-23-8 | Skin care |
Neurotransmitters are chemical messengers essential for bodily functions. They transmit chemical signals from one neuron (nerve cell) to the next target cell (nerve cell, muscle cell, or gland). Communication between two neurons occurs in the synaptic cleft (the small gap between nerve cell synapses). Neurotransmitters are released into the synaptic cleft from presynaptic vesicles when presynaptic neuronal activity is stimulated, a process dependent on Ca2+. The released neurotransmitters, via chemical signals, briefly transform electrical signals propagated along the axon into chemical signals, triggering specific reactions in the receiving neuron. They interact with neurotransmitter receptors on target cells.
Neurotransmitters can affect neurons in three ways: excitatory, inhibitory, or modulatory. Excitatory neurotransmitters promote the generation of electrical signals in the receiving neuron, while inhibitory neurotransmitters prevent it. It's important to note that neurotransmitter inhibitors are not inhibitory neurotransmitters.
From a chemical structure perspective, neurotransmitters can be classified into four types:
In skincare, inhibiting or eliminating the formation of wrinkles is crucial. One reason for the formation of wrinkles is excessive pressure stimulation on facial muscles. From a physiological perspective, the release of the neurotransmitter acetylcholine (ACh) can cause muscle contraction. This process begins at the presynaptic terminal, where protein-protein interactions lead to the influx of vesicles containing acetylcholine to the neuronal membrane. Once there, they fuse with the membrane and release acetylcholine into the cholinergic synapse. Releasing acetylcholine requires calcium ions and a specific transport protein chain called the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. The SNARE complex assists in the fusion of acetylcholine vesicles with the neuronal membrane and the subsequent release of acetylcholine. ACh passes through this synapse to the other side, where it can stimulate the response of the next cell (e.g., muscle cell).
The other side of the synapse is the target cell membrane, which requires acetylcholine receptors to capture the released acetylcholine. There are two types of receptors—nicotinic and muscarinic. Most muscle cells (except for heart and some smooth muscles) have nicotinic receptors. Acetylcholine, when binding to its receptors on muscle cells, induces muscle contraction by releasing Ca2+ ions and may lead to the formation of wrinkles.
The release of acetylcholine is a complex process. In simple terms, a vesicle-associated membrane protein called SNAP-25 (Synaptosomal-Associated Protein, 25kDa) plays a crucial mediating role. SNAP-25 is a component of the SNARE complex responsible for the fusion of acetylcholine vesicles with the neuronal membrane and the subsequent release of acetylcholine. Some synthetic peptides used in anti-aging cosmetics mimic the sequence of the N-terminal region of SNAP-25 (AA12-AA17) and compete with SNAP-25, disrupting protein-protein binding involved in acetylcholine release. This inhibition leads to a reduction in muscle contraction that causes the formation of wrinkles. These peptides, specifically inhibiting neurotransmitter release (such as acetylcholine), relaxing muscles, and softening wrinkles, are called neurotransmitter-inhibiting peptides.
Botulinum toxin is a neurotoxic protein produced by Clostridium botulinum and related species. It can cleave SNAP-25 protein. As mentioned earlier, SNAP-25 protein mediates the fusion of vesicles containing acetylcholine with the neuronal membrane. Activated botulinum toxin cleaves SNAP-25, a key protein in the SNAP-25 protein complex responsible for vesicle fusion. Cleaved SNAP-25 cannot mediate the fusion of vesicles with the host cell membrane, meaning vesicles containing acetylcholine cannot bind to the intracellular cell membrane. This prevents the release of acetylcholine from the presynaptic terminal of the nerve-muscle junction, terminating the transmission of nerve signals and causing flaccid paralysis. Therefore, botulinum toxin, commercially used for medical and cosmetic purposes, is considered relatively safe and effective for reducing facial wrinkles, especially in the upper third of the face.
Three botulinum toxin approved by the FDA are as follows: Onabotulinum toxin A (Botox®/Vistabel®); Abobotulinum toxin A (Dysport®/Azzalure®); Incobotulinum toxin A (Xeomin®/Bocouture®).
In addition to botulinum toxin, common peptide neurotransmitter inhibitory cosmeceutical products are summarized in the table below:
Product Name | Active Peptide | Function | In vitro Effects |
Vialox | Pentapeptide-3 | Anti-aging; Anti-wrinkle; Muscle relaxant | Competitively antagonizes acetylcholine receptors and combines with brain opioid receptors, closing calcium channels, leading to muscle relaxation (in vitro); Reduces muscle contraction by 71% within 1 minute, and 58% after 2 hours (in vitro). |
Vanistryl | Acetyl Tripeptide-30 Citrulline, Pentapeptide-18 | Skin tightener; Delivery carrier | Inhibits extracellular matrix (ECM) degradation (in vitro); Regulates acetylcholine release in neuronal cell cultures by blocking Ca2+ entry. |
Argireline | Acetyl hexapeptide-8 | Anti-aging; Anti-wrinkle; Muscle relaxant | Regulates SNARE complex formation (in vitro); Modulates release of catecholamines in chromaffin cells (in vitro). |
Argirelox | Acetyl hexapeptide-8, Pentapeptide-18 | Anti-aging; Anti-wrinkle; Muscle relaxant | Regulates glutamate release (in vitro). |
BONT-L Peptide Solution | Palmitoyl hexapeptide-19 | Anti-aging; Anti-wrinkle; Muscle relaxant | Inhibits 30% of SNARE protein complex. |
Calmosensine | Acetyl dipeptide-1cetyl ester | Anti-aging; Anti-wrinkle; Skin moisturizer; Soothing agent; Smoothing agent; Cooling agent | Stimulates keratinocyte release of pre-opiomelanocortin; Gradual reduction in muscle contraction, complete muscle inhibition within 2 hours at levels as low as 1 ppm (in vitro). |
Inyline | Acetyl hexapeptide-30 | Anti-aging; Anti-wrinkle; Muscle relaxant | Reduces acetylcholine accumulation, a critical step in post-synaptic function at the neuromuscular junction (NMJ) (in vitro). |
Leuphasyl | Pentapeptide-18 | Anti-aging; Anti-wrinkle; Muscle relaxant | Regulates glutamate release in neuronal cell cultures (in vitro). |
Snap 8 | Acetyl octapeptide-3 | Anti-aging; Anti-wrinkle; Muscle relaxant | Inhibits SNARE complex formation (in vitro); Modulates release of catecholamines in chromaffin cells (in vitro); Regulates glutamate release in neuronal cell cultures (in vitro). |
Syn-ake | Dipeptide diaminobutyroyl benzylamide diacetate | Anti-aging; Anti-wrinkle; Smoothing agent | Reversible antagonist of muscle nicotine acetylcholine receptors (nAChR) (in vitro); Inhibits post-synaptic membrane uptake of Na to weaken muscle cell contraction (in vitro); Mimics/imitates waglerin-1 functionality. |
X50 Myocept | Palmitoyl hexapeptide-52, Palmitoyl heptapeptide-18 | Anti-aging; Anti-wrinkle; Muscle relaxant | Reduces calcium entry into neurons, inhibits SNARE protein complex formation; Reduces neuronal exocytosis. |
References: